The hidden Innovation Debt
How deferred decisions block tomorrow's strategy
Not every innovation project that continues is actually making progress. When decisions are repeatedly postponed, innovation debt begins to accumulate. It ties up resources, preserves outdated assumptions, and leaves too little room for new strategic priorities.
Many innovation portfolios contain projects that are neither clear failures nor genuine successes. The prototype works in principle, but the customer value has not yet been proven. The technology still appears promising, but the business case remains vague. There is not enough evidence to justify a larger investment – yet supposedly not enough reason to stop the project either.
So the team continues validating, refining, and reassessing. The project receives another quarter. Then another.
This is exactly how innovation debt develops.
What is innovation debt?
Innovation debt describes the long-term cost of deferred decisions in innovation management. It accumulates when a company neither advances, redirects, nor ends an initiative, even though critical questions have remained unanswered for an extended period.
Uncertainty itself is not the problem. It is an inherent part of innovation. It becomes a problem when teams are no longer systematically reducing that uncertainty, while resources continue to flow into the project.
Much like financial debt, innovation debt comes with interest. But that interest does not appear as a separate line item in the budget. It shows up as constrained development capacity, longer coordination cycles, unclear responsibilities, and missed alternatives.
There is also a strategic cost. The longer legacy projects remain in the portfolio, the less room there is for new initiatives that may be better aligned with current market conditions.
A project that shloud have reached a decisiom long ago
Consider a midsized food manufacturer developing a plant-based dessert using a novel fermentation process. The first production trial works. A major grocery retailer expresses interest but repeatedly postpones its decision on whether to carry the product.
At the same time, several critical questions remain unanswered: Will product quality remain consistent at commercial scale? Are consumers willing to pay the intended premium? And can the product succeed economically beyond a single retail customer?
No one wants to end the project during the portfolio review. After all, the company has already invested time and money. Yet there is not enough evidence to justify full-scale commercialization. The decision is therefore to continue validating the concept.
Six months later, little has changed. Three food scientists still spend part of their time on the project. Procurement remains in contact with suppliers of the specialized cultures and ingredients. Sales continues to present the concept in retailer meetings without being able to provide a firm launch date. Manufacturing capacity is tentatively reserved for additional trial runs.
Meanwhile, demand is growing for a reduced-sugar version of an established product line. But the same specialists needed to develop it are still involved in the plant-based dessert project.
The older initiative is no longer just generating ongoing costs. It is preventing the company from pursuing a potentially more important strategic opportunity. A deferred project decision has become innovation debt.
Why innovation debt accumulate so easy
Innovation projects are rarely continued based on objective criteria alone. Previous investments, personal commitment, and internal expectations often play an equally important role.
The well-known sunk-cost-effect leads people to factor previously invested time and money into decisions about the future. A more rational question would be: Knowing what we know today, would we start this project again?
Another factor is that ending a project is often perceived as failure. Approving another round of funding can be easier to justify than shutting down an initiative that teams have supported for months. As a result, what should be a clear no turns into a temporary maybe.
A lack of decision criteria also contributes to innovation debt. If acompany does not define at the outset which assumption must be validated by which date, a project can continue almost indefinitely. Every disappointing result simply leads to one more test.
Five warning signs in the innovation portfolio
Innovation debt can be identified before it slows down the entire portfolio. Typical warning signs include:
- A project remains in "validation" across several review cycles without any change to the central question being tested.
- The next milestone describes an activity rather than a decision.
- Timelines and value propositions are repeatedly adjusted, while budget and resources continue automatically.
- No one has a clear mandate to stop or fundamentally redirect the project.
- The main argument for continuing an initiative is the amount alredy invested rather than its future potential.
Not every long-running innovation project is a problem. Technology development in particular can take years. The important question is whether the project continues to generate relevant knowledge, remains strategically justified, and is progressing toward clearly defined milestones.
Patience is not the same asstagnation.
Reducing innovation debt without ending projects to soon
The solution is not to shut down uncertain projects as quickly as possible.That would eliminate precisely the initiatives that require time and genuine research effort. Instead, companies need to connect uncertainty with binding decisions.
Every project should therefore have a decision date in addition to its next phase of work. By that date, the team must know which assumption is being tested, what evidence is required, and what the result will trigger.
The outcome does not automatically have to be termination. There are three valid decisions: invest, redirect, or stop.
A recurring innovation debt review can also help. Rather than asking only how far a project has progressed, decision-makers should ask four different questions:
- Which critical assumption has been resolved since the last review?
- Would we start this initiative again based on what we know today?
- What specific decision must be made next?
- What strategic alternative could be pursued with the same resources?
The final question is particularly important. A project does not compete with doing nothing. It competes with other investment opportunities. Only when those alternatives are visible can leaders assess the true cost of continuing.
Tomorrow's strategy needs room to move
Innovation debt accumulates quietly. No single project brings an entire portfolio to a standstill. But when too many decisions are deferred, resources remain tied to yesterday’s priorities.
A strong innovation portfolio therefore contains more than ideas, projects, and budgets. It also contains clear decisions. That requires the courage to fund promising initiatives decisively – and the willingness to redirect or systematically end others.
A project does not have strategic value simply because it has survived for a long time. Its value lies in whether it continues to contribute to a relevant future.
